ADVERTISEMENT
Blood clots should be listed as rare Johnson & Johnson side effect: EMAThe European Medicines Agency said in a statement it had found a 'possible link' between the jab and the clot
AFP
Last Updated IST
Credit: Reuters File Photo
Credit: Reuters File Photo

The EU's drug regulator said Tuesday that blood clots should be listed as a "very rare" side effect of the Johnson & Johnson coronavirus vaccine but that its benefits still outweighed the risks.

The European Medicines Agency said in a statement it had found a "possible link" between the jab and the clot, and that its safety committee "concluded that these events should be listed as very rare side effects of the vaccine".

ADVERTISEMENT
(Published 20 April 2021, 21:30 IST)